140
Views
1
CrossRef citations to date
0
Altmetric
Nephrology

Incidence, predictors, clinical outcomes, and economic burden of recurrent acute kidney injury: a retrospective cohort study

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 399-407 | Received 29 Jun 2022, Accepted 30 Jan 2023, Published online: 14 Feb 2023

References

  • Kellum JA, Lameire N, Group KAG. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013;17(1):204.
  • Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482–1493.
  • Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007; 18(4):1292–1298.
  • Alshelleh SA, Oweis AO, Alzoubi KH. Acute kidney injury among nonagenarians in Jordan: a retrospective case-control study. IJNRD. 2018;11:337–342.
  • Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961–973.
  • Ikizler TA, Parikh CR, Himmelfarb J, et al. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021;99(2):456–465.
  • Lafrance JP, Miller DR. Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2010;21(2):345–352.
  • Melo FAF, Macedo E, Fonseca Bezerra AC, et al. A systematic review and meta-analysis of acute kidney injury in the intensive care units of developed and developing countries. PLOS One. 2020;15(1):e0226325.
  • Ostermann M, Cerda J. The burden of acute kidney injury and related financial issues. Contrib Nephrol. 2018;193:100–112.
  • Oweis AO, Alshelleh SA. Incidence and outcomes of acute kidney injury in octogenarians in Jordan. BMC Res Notes. 2018; 11(1):279.
  • Oweis AO, Alshelleh SA, Momany SM, et al. Incidence, risk factors, and outcome of acute kidney injury in the intensive care unit: a single-center study from Jordan. Crit Care Res Pract. 2020;2020:8753764.
  • Ruiz-Criado J, Ramos-Barron MA, Fernandez-Fresnedo G, et al. Long-term mortality among hospitalized non-ICU patients with acute kidney injury referred to nephrology. Nephron. 2015;131(1):23–33.
  • Wu VC, Wu CH, Huang TM, et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014;25(3):595–605.
  • Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370.
  • Collister D, Pannu N, Ye F, et al. health care costs associated with AKI. Clin J Am Soc Nephrol. 2017;712(11):1733–1743.
  • Dasta JF, Kane-Gill S. Review of the literature on the costs associated with acute kidney injury. J Pharm Pract. 2019;32(3):292–302.
  • Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011: statistical brief #160. Healthcare cost and utilization project (HCUP) Statistical briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006.
  • Harris DG, Koo G, McCrone MP, et al. Recurrent kidney injury in critically ill surgical patients is common and associated with worse outcomes. J Trauma Acute Care Surg. 2014;76(6):1397–1401.
  • Hounkpatin HO, Fraser SDS, Glidewell L, et al. Predicting risk of recurrent acute kidney injury: a systematic review. Nephron. 2019;142(2):83–90.
  • Holmes J, Geen J, Williams JD, et al. Recurrent acute kidney injury: predictors and impact in a large population-based cohort. Nephrol Dial Transplant. 2020;35(8):1361–1369.
  • Liu KD, Yang J, Tan TC, et al. Risk factors for recurrent acute kidney injury in a large population-based cohort. Am J Kidney Dis. 2019;73(2):163–173.
  • Sako K, Furuichi K, Yamamura Y, et al. Association between the recurrence period of acute kidney injury and mortality: a single-centre retrospective observational study in Japan. BMJ Open. 2019;169(6):e023259.
  • Rodriguez E, Arias-Cabrales C, Bermejo S, et al. Impact of recurrent acute kidney injury on patient outcomes. Kidney Blood Press Res. 2018;43(1):34–44.
  • Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743–750.
  • Perazella MA. Pharmacology behind common drug nephrotoxicities. Clin J Am Soc Nephrol. 2018;13(12):1897–1908.
  • Siew ED, Parr SK, Abdel-Kader K, et al. Predictors of recurrent AKI. J Am Soc Nephrol. 2016;27(4):1190–1200.
  • Harel Z, Wald R, Bargman JM, et al. Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int. 2013;83(5):901–908.
  • Ortiz-Soriano V, Alcorn JL 3rd, Li X, et al. A survey study of self-rated patients’ knowledge about AKI in a post-discharge AKI clinic. Can J Kidney Health Dis. 2019;6:205435811983070.
  • Siew ED, Peterson JF, Eden SK, et al. Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol. 2012;23(2):305–312.
  • Saran R, Li Y, Robinson B, et al. US renal data system 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;67(3 Suppl 1):Svii, S1–305.
  • Al-Azzam SI, Al-Husein BA, Abu-Dahoud EY, et al. Etiologies of acute renal failure in a sample of hospitalized Jordanian patients. Ren Fail. 2008;30(4):373–376.
  • Chisholm-Burns MA, Schwinghammer TL, Malone PM, et al. Pharmacotherapy Principles and Practice. 5th ed. USA: McGraw Hill; 2018.
  • Gameiro J, Fonseca JA, Outerelo C, et al. Acute kidney injury: from diagnosis to prevention and treatment strategies. J Clin Med. 2020;9(6):1704.
  • Kellum JA. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.
  • de Aquino Moura KB, Behrens PMP, Pirolli R, et al. Anticoagulant-related nephropathy: systematic review and meta-analysis. Clin Kidney J. 2019;12(3):400–407.
  • Sergey V, Brodsky BHR, Hebert LA. Anticoagulant-related nephropathy uptodate 2020. [updated May 22, 2020]. Available from: https://www.uptodate.com/contents/anticoagulant-related-nephropathy.
  • Rolland AL, Garnier AS, Meunier K, et al. Drug-induced acute kidney injury: a study from the French medical administrative and the french national pharmacovigilance databases using Capture-recapture method. J Clin Med. 2021;10(2):168.
  • Al-Azayzih A, Al-Azzam SI, Alzoubi KH, et al. Nonsteroidal anti-inflammatory drugs utilization patterns and risk of adverse events due to drug–drug interactions among elderly patients: a study from Jordan. Saudi Pharm J. 2020;28(4):504–508.
  • Albsoul-Younes AM, Jabateh SK, Abdel-Hafiz SM, et al. Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the Jordanian patient population. Saudi Med J. 2004;25(7):907–911.
  • Khan S, Loi V, Rosner MH. Drug-induced kidney injury in the elderly. Drugs Aging. 2017;34(10):729–741.
  • Pierson-Marchandise M, Gras V, Moragny J, et al. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database. Br J Clin Pharmacol. 2017; Jun83(6):1341–1349.
  • Brown JR, Rezaee ME, Marshall EJ, et al. Hospital mortality in the United States following acute kidney injury. Biomed Res Int. 2016;2016:4278579.
  • Yokota LG, Sampaio BM, Rocha EP, et al. Acute kidney injury in elderly patients: narrative review on incidence, risk factors, and mortality. Int J Nephrol Renovasc Dis. 2018;11:217–224.
  • Cardinal-Fernandez P, Ferruelo A, Martin-Pellicer A, et al. Genetic determinants of acute renal damage risk and prognosis: a systematic review. Med Intensiva. 2012;36(9):626–633.
  • Silver SA, Long J, Zheng Y, et al. Cost of acute kidney injury in hospitalized patients. J Hosp Med. 2017;12(2):70–76.
  • Hammad EA, Alabbadi I, Taissir F, et al. Hospital unit costs in Jordan: insights from a country facing competing health demands and striving for universal health coverage. Health Econ Rev. 2022;12(1):11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.